03/17/23 5:20 PMOTC : PBSV low floatPharma-Bio Serv Announces Results for the Quarter Ended January 31, 2023Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, chemical, medical device,RHEA-AIneutral
03/01/23 9:15 AMOTC : PBSV dividendslow floatPharma-Bio Serv Announces Special DividendPharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, medical device, cosmetic, foodRHEA-AIneutral
02/07/23 9:25 AMOTC : PBSV low floatPharma-Bio Serv Retains Investment Banking Firm ACP Capital to Provide Investment Banking and M&A Advisory ServicesPharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory, compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, medical device,RHEA-AIneutral
01/30/23 5:07 PMOTC : PBSV low floatPharma-Bio Serv Announces Full Year ResultsPharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), is a regulatory, compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, medical device,RHEA-AIneutral
09/14/22 4:35 PMOTC : PBSV low floatPharma-Bio Serv Announces Results for the Three and Nine Months Ended July 31, 2022Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm providing services to the pharmaceutical, biotechnology, chemical, medical device,RHEA-AIneutral
06/14/22 4:50 PMOTC : PBSV low floatPharma-Bio Serv Announces Results for the Three and Six Months Ended April 30, 2022Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm providing services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic,RHEA-AIneutral
03/17/22 5:30 PMOTC : PBSV low floatPharma-Bio Serv Announces Results for the Quarter Ended January 31, 2022Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, chemical, medical device,RHEA-AIneutral
02/11/22 6:30 PMOTC : PBSV dividendslow floatPharma-Bio Serv Announces Full Year Results and Declares a Special DividendPharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory, compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, medical device,RHEA-AIneutral
11/15/21 7:00 AMOTC : PBSV dividendslow floatPharma-Bio Serv Announces Special DividendPharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory, compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, medical device,RHEA-AIneutral
09/14/21 4:15 PMOTC : PBSV low floatPharma-Bio Serv Announces Results for the Quarter Ended July 31, 2021Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory, compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, medical device,RHEA-AIneutral